Object. Wound complications are uncommon following deep brain stimulation (DBS) surgery. However, certain key technical steps can be performed in each procedure to minimize this still troublesome risk. The authors reviewed the incidence and management of all hardwarerelated wound dehiscences and infections in a large patient series.
O ver the past 20 years DBS has become a widely recognized technique for reversible modulation of brain function that is adjunctive to medical man agement of movement disorders. The therapeutic effects of DBS are clearly evident and applications of this tech nique for a larger spectrum of diseases are growing. As this technique evolves, wound complications (including infection) related to the implanted hardware will inevi tably arise and need to be treated. The risk of infectious complications from DBS is reviewed in a number of re ports in the literature, and varies from 0% to more than 15% per patient. [3] [4] [5] [6] 9, 13, 15, 17, 18, [21] [22] [23] [24] 26, 27, 31, 33, [36] [37] [38] However, in terpre tationoftheseratesisdifficultbecausethedefini tion of infection is variable and is further complicated by low series volume, restricted perioperative analysis, and limited discussion of cranial wound management. Few reports detail the comprehensive incidence and manage ment of all postoperative wound complications that are selflimited, in addition to those requiring a return to surgery, 38 without excluding noninfectious wound dehis cences and/or erosions over a long followup period. 26, 38 Given that the number of DBS hardware implants will continue to increase and new applications for this pro cedure appear on the horizon, we must determine how to prevent as well as manage such complications, if and when they arise, in the most expeditious way possible.
In this study we evaluated the incidence and manage ment of peri and postoperative wound complications re lated to DBS hardware implantation, including infection, Management of devicerelated wound complications in deep brain stimulation surgery wound dehiscence, and/or erosion in a large series of con secutive patients treated by 1 primary surgeon (R.K.S.). We offer our preventative surgical regimen as well as a management strategy for devicerelated complications arising at all incisions, designed to spare complete hard ware removal when possible, and to maximize the treat mentbenefitforthepatient.
Methods

Study Criteria
All patients undergoing new DBS implantation sur gery between January 2002 and December 2010 were entered into a database. These patients were identified based on consecutive operative reports of 1 primary sur geon (R.K.S.) operating at multiple campuses in Hous ton, Texas; procedures were performed at The Methodist Hospital, Saint Luke's Episcopal Hospital, and Memorial Hermann Hospital. The database was crosschecked with the manufacturers' records of hardware implantations performed at the participating institutions for data veri fication. Implantations of DBS devices were primarily Medtronic implants, with a few investigational device im plants (Libra DBS System, St. Jude Medical Neuromodu lation). For retrospective analysis, the study period was determined to allow a minimum followup of 6 months.
Prior to beginning this research endeavor, institu tional review board approval was sought and granted at each institution for this retrospective chart review. The chartsofthepatientsidentifiedinthisdatabasewereana lyzed for the occurrence of peri and postoperative wound complications, including infections both selflimited by antibiotics alone and those requiring a return to surgery for management. Perioperative infections were defined as those occurring spontaneously within 12 months of an original implantation (nonreplacement), without a di recttraumacausation.Superficialwoundinfectionswere definedasinduration,redness,orpersistentcrustingdi rectly over a hardware component; clinical evidence of device involvement was assumed if there was cellulitis or purulent drainage emanating from an incision over a de vice implant. The latter infections requiring surgical re vision did involve obtaining intraoperative microbiologi cal cultures from the hardware or from fluid in contact with hardware. Implantable pulse generator replacement procedures were identified within this database and the incidences of complications arising from them were doc umented separately. All wound dehiscences, device ero sions, and delayed infections occurring at different time points postoperatively within the 9 years of the study, ei ther spontaneously or trauma induced, arising from the original implantation or following a replacement pro cedure, were identified and cataloged individually. The charts of patients with wound complications, either self limited or requiring a return to surgery, were reviewed to assess the success of antibiotics alone, debridement alone, or partial hardware removal.
Surgical Techniques
All patients underwent either stereotactic MRI, or preoperative MRI that was integrated into a cranial CT based 3D stereotactic coordinate system by landmark based image fusion. The difference in MRI technique used was based on availability and the standard protocol established at each institution. In all procedures, the Lek sell series G (Elekta) frame was used. Targeting of the various structures was usually indirect and then modi fiedbasedonthepatient'sanatomy,ashasbeendetailed elsewhere. 16 Implantation of leads was often performed during the same procedural time as placement of the lead ex tensions and IPG early in the series, but by 2004 these largely became staged procedures. Stage 1 was usually performed under local anesthesia for lead placement and Stage 2 under general anesthesia for lead extenders and IPG placement.
Cefazolin (or vancomycin, if the patient had a penicil lin allergy) was administered before surgery. Oral cepha lexin(orciprofloxacin/clindamycinifthepatienthadapen icillin allergy) was routinely administered to all patients for 7 days after the procedure as prophylactic therapy. Depending on the procedure, the entire scalp or the neck, chest, and/or abdomen were clipped of hair, degreased, and then prepared with 2% chlorhexidine gluconate and 70% isopropyl alcohol (ChloraPrep; Enturia, Inc.).
Stage 1.
For Stage 1 procedures, a slightly curved frontal incision is placed at or near the coronal suture to allow access to bilateral bur holes, which are placed pos terior to the incision. A 3cm parietal incision is made in a curvilinear fashion as the access point for the future Stage 2 extension placement procedure, perpendicular to the direction of the lead. Low-profile bur hole ring and cap systems provided by the manufacturer are placed to secure the lead, and redundant lead wiring is coiled in a subgaleal fashion. Grooves are made with a bur in the parietal bone to recess the future extension connections; the proximal part of the lead is coiled at this location for future access.
Microelectrode recording is routinely performed for all targets except for the ventral intermediate nucleus of the thalamus, where the Leksell insertion kit (Elekta) is used instead of microelectrode recording at The Meth odist Hospital and Saint Luke's Episcopal Hospital. At all operative locations, intraoperative test stimulation is performed to verify target accuracy and lack of sustained side effects.
Stage 2. Stage 2 procedures involve reopening the pa rietal incision to externalize the leads and tunneling lead extensions to a 5cm linear subclavicular and/or subcostal incision, which lies superior to the newly created subcu taneous pocket for the IPG. All incisions are closed with 30 resorbable sutures in either the galea or deep subcu taneous tissue, followed by either skin staples or 30 run ningmonofilamentnylon.PriortoclosureinbothStage 1 and 2, irrigation with povidoneiodine solution diluted to near 1% concentration is performed at each incision.
Statistical Analysis
All statistical analyses were performed using stan dard statistical software (SPSS, version 17.0). Risk factors for the occurrence of infection, such as age, diagnosis, date of surgery, and institution, were analyzed using mul tivariate logistic regression. The Student ttest with equal variances was used to compare the following variables between the set of patients requiring return to surgery and those with selflimited infections: age, diagnosis, and time postsurgery until presentation of spontaneous wound infection. Initial antibiotic choice was compared between the 2 groups as well using the Fisher exact test. 
Results
Patient Characteristics
Atraumatic Presentations Less Than 12 Months From Original Implantation
The rate of atraumatic presentation of infection and/ or erosion occurring less than 12 months from original DBS implantation, requiring additional surgery, was 1.24% (9/728) per patient ( Table 2) . Five infections were found to originate at the bifrontal incision, 3 at the left parietal connection incision, and 1 at the IPG site. If self limited superficial infections (those treated successfully by antibiotics alone without further surgery) are included, the incidence was 2.2% (16/728) per patient ( Table 3) . Six of 7 of these selflimited infections originated at the IPG site, whereas 1 was at the bifrontal incision.
The perlead risk of infection was calculated based on the origin of the infection: bifrontal and parietal wound infections were assumed to be associated with 2 leads, whereas an infection accompanying a singlechannel IPG (such as Soletra or Libra) was assumed to be associated with 1 lead. Of those presentations that resulted in fur ther surgery for treatment, 17 DBS leads were associated with a device infection, with a calculated perlead risk of 1.27% (17/1333 leads); including all infection presenta tions, the perlead risk was 1.95% (26/1333 leads).
The mean age (± SD) of the 9 patients requiring fur ther surgery who presented less than 12 months from original implantation was 52.44 ± 15.62 years old (range 24-79 years old); that of all infections (n = 16) in this category was 54.87 ± 12.80 years old (range 24-79 years old).
Once the patients presented clinically, they were started on a course of oral antibiotics. The details of the antibiotic regimen are provided in Tables 2 and 3 . The mean duration of the antibiotic regimen for infections not requiring further surgery was 24 ± 13.7 days (range 7-42 days).
All 8 patients who presented with cranial wound complications were treated initially by debridement in an attempt to salvage the leads. Debridement followed by in travenous antibiotics was only successful in treating the infection in 2 patients, 1 each with bifrontal or parietal origin (25% success rate). One of 2 patients who eventu ally had the leads only removed (to spare the IPG) was successfully treated. The only infection originating from the IPG was treated by IPG removal alone and intrave nous antibiotics.
Themeantimetofirstsurgery(eitherwashoutorex plantation) after initial presentation in those patients in whom antibiotics failed to contain the infection was 32.78 ± 41.22 days (range 2-132 days), whereas the mean time to hardware explantation (n = 7) after initial presentation on antibiotics was 242.14 ± 331.98 days (range 13-942 days). If the outlier case is excluded, then the mean time to explantation after initial presentation (n = 6) becomes 126.17 ± 101.5 days (range 13-239 days), which is sig nificantlylongerthanthetimefrompresentationtoini tial surgery (p = 0.02, ttest). The majority of organisms cultured at the time of surgery were consistent with skin flora,withStaphylococcus aureus the most common or ganism.
Self-Limited Infections Versus Those Requiring Reoperation
The only variables that were significantly different between selflimited infections and those requiring reop eration were the time after implantation (postoperative day) to clinical presentation, as well as initial antibiotic choice;ageanddiagnosiswerenotsignificantlydifferent.
All of the 17 patients with hardwarerelated infec tions presented with localized swelling, erythema, or crusting at either the IPG, parietal, or frontal incision. Of these, each of the 9 patients who required further surgery presented additionally with localized drainage at one of these incisions over the evolution of their infection. Infections that were successfully treated by antibiot ics alone presented to clinic earlier (postoperative Day 16.4 ± 8.5 days) than those ultimately requiring further surgery (postoperative Day 89 ± 50 days), which was sig nificant (p = 0.002, t-test). This finding may be skewed because all patients were seen for suture removal within 2 weeks postoperatively, and therefore wound infections could be detected at that visit if they existed and then be treated. Initial antibiotic given upon presentation was significantly different between the 2 groups (p = 0.017, Fisher exact test), but this may be related to the time of presentation and relation to routine postoperative prophy laxis (see Discussion).
Atraumatic Device-Related Infection Presenting > 12 Months From Implantation
Two patients (0.2%) presented more than 12 months from original implantation; 1 was successfully treated by antibiotics alone, while another presenting with erosion over his IPG underwent successful partial hardware re moval with lead salvage, followed by replacement, only to have a new infection develop cranially requiring sub sequent partial and then total system removal.
Postrevision Device-Related Infections or Erosions
Five patients (0.7%) presented less than 12 months from revision of hardware. Two (0.2%) of these patients were successfully treated using antibiotics alone, and 3 (0.4%) required further surgery. One patient presented with a visible dehiscence 2 weeks after replacement and underwent debridement alone, without evidence of infec tion. Another patient demonstrated evolution of erythema from the IPG site to extension into the neck, requiring re moval of the IPG and extension, an intravenous antibiotic course, and then later replacement. Another patient pre sented with wound drainage at the IPG site that quickly evolved to erosions over both the IPG and parietal inci sions, leading to total system removal.
Trauma-Induced Wound Complications
Three patients (0.4%) presented with posttraumatic wound dehiscences over a component of their DBS sys tem, all requiring surgery. One patient presented with gross unilateral lead exposure at the bur hole after sus taining a fall, requiring removal alone, without sequelae. One patient presented with a parietal wound dehiscence following a fall and was successfully treated by intraoper ative wound washout alone. Following a seat belt injury, 1 patient suffered hematomata and dehiscences at his right chest and subcostal IPG sites; despite quick removal of IPGs and extensions alone, infection occurred and spread to later necessitate total system removal.
Risk Factors for Device-Related Infection
Patient age, diagnosis, date, and place of surgery were not predictive of infection risk, based on a multivariate logistical regression analysis. Although 8 of 9 infections requiring reoperation within 12 months of the initial DBS hardware implantation were the result of staged proce dures, the majority of total cases performed were staged; therefore, this finding is expected and not considered a risk factor. Other potential risk factors such as comor bidities that could cause immunocompromise (diabetes, and idiopathic or acquired autoimmune diseases) could not be analyzed due to their lack of incidence in the in fected patient group. All of the patients (100%) requiring reoperation for wound infection 12 months from surgery and5of7patientspresentingwithsuperficialinfections † Refers to the day number after implantation when 1) antibiotics were begun (number of days since implantation) and 2) when antibiotics were stopped (number of days since implantation).
each had 2 implanted Soletra IPGs. However, we do not interpret these data as a risk for infection because Soletra IPGs comprised 92% of all implanted IPGs during the study period, and accordingly it is expected that most in fected patients would be from this group. Also, only 1 of 9 patients requiring a return to surgery had the origin of infection at the IPG site, further removing the IPG type as causative.
Lead Replacements
During this 9year series, 22 DBS leads were replaced in 13 patients who underwent their original implantation by a different surgeon at an outside institution; 32 DBS lead replacements were performed in patients originally implanted after 2002 by the same surgeon (R.K.S.; Table  1 ). None of these patients developed an infection. These 32 leads are included in the total number of implanta tions because they represent new lead placements, which occurred after removal of an old lead, under the same de tailed stereotactic procedure followed by a separate new lead extension and IPG placement.
Discussion
The risk of infectious complications in DBS is re viewed in a number of reports in the literature, varying from 0% to 15% per patient. [3] [4] [5] [6] 9, 13, 15, 17, 18, [21] [22] [23] [24] 26, 27, 31, 33, [36] [37] [38] However,interpretationoftheseratesisdifficultbecause the definition of infection is variable and is sometimes inclusive and/or exclusive of erosions and/or dehiscences without infection 26, 38 or infections that are selflimited. 38 In this paper we have detailed a categorical analysis of the incidence and management of all postoperative wound complications, over both a short term (< 12 months) and longer term. Perhaps of greater value is that the groups areclassifiedas"spontaneously"occurringascompared with those that are secondary to revision or trauma, both of which subject the system to potential recontamination. Eight of 9 infections that were grouped in the spontane ous (< 12 month) incidence group did, in fact, present less than 6 months from implantation, so these data strongly correlate with data from other large case series analyzing infections due to DBS hardware. 33 
Management of Spontaneous Atraumatic Wound Infections Presenting Less Than 12 Months
In the present series, 9 patients developed infections that required further surgery less than 12 months from original implantation ( Table 2) .
Cranial Origin. All 8 of 8 infections presenting with wound drainage at cranial incisions were first treated with a wound washout. This was performed in an attempt to save the hardware, or at least have the patient continue to benefit from stimulation for a longer period of time. Unfortunately, only 1 of 5 infections originating bifron tally and 1 of 3 infections originating parietally were suc cessfully treated by wound washout alone. This failure rateissimilartothefindingsofotherpublishedstudies. In the series by Sillay et al., 33 2 patients presented with in fections originating at their frontal incisions and 2 at their parietal incisions. Wound washout was attempted in only 1 infection originating frontally, which ultimately failed to control the infection. All 4 of these patients underwent complete hardware removal; there was no attempt at lead removal only. In the series by Oh et al., 26 5 of 6 patients with infections underwent unsuccessful initial hardware salvage attempts via wound debridement followed by in travenous antibiotics. All 5 of these patients had total de vice removal.
Cranial wound debridements have been reported to be successful in the literature. Temel et al. 36 initially performed an operative debridement in 1 patient in their series, who presented with left frontal and right cervical wound dehiscences and purulent discharge despite anti biotics; this operation ultimately failed, but the patient only required removal of the right extension cable and IPG, sparing the leads, followed by further debridement, graciloplasty, and antibiotics.
It is interesting to note that in the 2 patients in our se ries in whom wound washout was successful, intraopera tive cultures revealed no growth. As implicated in other series 33 and in other surgical specialties involving hard ware implantation, 10 wounds contaminated with S. aureus are unlikely to be cured without hardware removal. In our series, 4 of the 7 patients' wounds ultimately requiring hardware removal were positive for S. aureus, supporting this position.
This raises the question of whether incision and de bridement of wound dehiscence and/or infection occur ring cranially is the best initial step. As stated above, in the current series, the mean time to explantation after pre sentation on initial antibiotics was more than 126 days in 6patients,whichis94dayslongerthanthetimetofirst surgery (wound washout in 8 of 9 patients). This differ enceintimeissignificant(p=0.02)andcanbeviewedas either a delay in the likely inevitable total explantation, or converselyasarealgaininbenefitderivedfromleaving the stimulation in situ. This protracting of the treatment regimen by more than 4 months is meaningful, because none of the patients who had their entire systems ex plantedlaterunderwentreimplantation(confirmedbythe Medtronic database). If immediate removal of hardware asthefirstsurgeryoccurredinthesepatients,thenthey wouldhavebenefitedlessfromDBSoverall.Reasonsfor this may include the possibility that the initial surgery was too painful a process (personal patient communica tion).
Thus, although infections originating cranially are, fortunately, a rare occurrence, the larger number of cases studied in this series gives us more evidence that perhaps the initial treatment should be a wound incision and de bridement, in the hope of prolonging the benefit from stimulation and possibly succeeding at ending the infec tion. Initially attempting to keep the system intact should be tried in these rare cases, followed by partial device removal (removing the leads and sparing the IPGs) in the hope of future reimplantation. This course, however, may ultimately fail, requiring total system removal and pro longed antibiotic administration. As should be the case in all surgery, communication and counseling with each individual patient needs to be performed so that an in formed decision about the next step in the process can be made.
Origin of the IPG. In most series reported in the lit erature, the presenting infection was over the IPG site in the majority of infected patients. 6, 24, 33, 36 In this present se ries there was only 1 infection originating over the IPG, which was ultimately treated by IPG and associated ex tension removal, followed by intravenous antibiotics and reimplantation 2 months later, saving the brain leads. This leadsalvage technique through partial hardware removal has been reported to be successful by others, 22, 24, 33, 36 and our data certainly corroborate that success.
Management of Wound Dehiscence and/or Erosion
Wound washouts were the end treatment option for 4 patients, who required no further surgery or device re moval. Three of these patients presented with wound re opening without associated induration, erythema, drain age, or other signs of infection. Likely in these instances, the simple washout and postoperative antibiotic regimen was successful because it allowed wound closure and it was performed in a timely manner, within a few days of presentation, before there was clear evidence of infection.
Management of erosions without evidence of infec tion is not prominently noted in the literature because most patient series combine these complications. Oh et al. 26 reported 8 of 12 erosions and/or infections in their series of 79 patients, with 7 of these occurring at the con nector site and 1 at the IPG. Only 1 patient was success fully treated by wound washout, with the others undergo ing hardware removal. In contrast, Voges et al. 38 reported only 1 patient with an erosion at the connector site that was managed by simple debridement and transposition of the connector, but they accounted for this 1 case as due to ahigh-profileconnectionthathassincebeenabandoned. Assupportedbyourdata,wefindthatdebridementalone is sufficient initially in the cases of dehiscence and/or erosion without evidence of infection.
Source of Infection
We did not observe a cerebral infection in any patient in this series. Although some series show a lower inci dence of infection at cranial incisions, 33 8 of 9 presenting infections requiring a return to surgery for management originated at either the bifrontal or parietal locations. It is interesting that this was the case, given that our overall infection rate requiring reoperation was lower than most, if not all, rates in other published series. Some contend that this higher rate of infection may be due to a lack of adequate sterile technique or exteriorization of leads. 9, 26, 35 However, Oh et al. 26 reported 4 of 10 infections originat ing at the bur hole, and 5 of 10 infections at the connec tor site, but report that most of these occurred after 12 months from implantation, and discount the brief 1week externalization period as causative.
Sillay et al. 33 reported 4 of 19 infections originating cranially; of the 420 patients in their series, this results in a risk of 0.95% per patient. In our series, 8 of 728 patients presented with infections of cranial origin, of similar in cidence (1.1%) to this larger series.
Antibiotic Choice in Relation to Presentation
All patients are given 1 week of cephalexin treat ment for prophylaxis postoperatively, or ciprofloxacin/ clindamycin if there is a penicillin allergy, and then re turn to the clinic for suture or staple removal within 1-2 weeks. Interestingly, the observation that selflimited infections presented at a significantly earlier time than those requiring further surgery is likely (and logically) dependent upon this postoperative visit, at which a nurse and/or physician can inspect and treat wounds causing concern.
The timing of presentation of such wounds in relation to the postoperative visit also likely affects the antibiotic choice, as this initial antibiotic given upon presentation also differed significantly between the 2 groups. Five of 7 infections that were ultimately cured by antibiotics alone presented within 2 weeks of surgery. Four of these 7 patients returning with incision concerns despite pro phylaxisreceivedlevofloxacin;2ofthe7thatcontinued on cephalexin experienced minor wound appearances that were of concern (slight redness). One patient contin uedonciprofloxacinduetoapenicillinallergy.Thereis nofinalproofoforganism,butlikelytheinfectionswere treated successfully due to early treatment using an anti staphylococcal antibiotic. Fluoroquinolones do not dem onstratebetterefficacyagainstgram-positivecoccithan cephalexin, 12 and because this group constitutes the gross majority of skin incision offenses, the switch to such an antibiotic after prophylaxis with cephalexin in such a wound is solely anecdotal.
Of the 9 patients who ultimately required reopera tion, cephalexin was restarted in 4 patients because they presented well after the prophylaxis period ended. Three patientswhoweregivenciprofloxacinpresentednearthe early term in this series (2 of 3), had more worrisome ap pearing wounds (2 of 3), and were penicillin allergic (1 of 3). One patient was only placed on intravenous vancomy cin initially prior to reoperation. Methicillinsensitive and resistant S. aureus was the offending organism in 4 of 9 proven cultures and was assumed to be the organism in the 4 cultures showing no growth, based on other series' experiences of hardware needing removal for cure. 10, 33 Cephalexin failed to treat two MRSA infections, as can be expected retrospectively. It can be hypothesized that if S. aureuswasindeedmostcommon,thenciprofloxa cin was a poor choice. We have abandoned this choice as initial prophylaxis in favor of clindamycin (in peni cillin-allergicpatients),whichhasbetterefficacyagainst gram-positivecoccithanciprofloxacin. 12 Furthermore, no patient in this series given clindamycin for postoperative prophylaxis presented with an infection (only 1% of pa tients, most in 2010).
Current Technique to Minimize Infection Risk and Prophylaxis for Infection
The surgical technique employed in each of the pro cedures presented in this series has varied little over time despite institutional differences, and continues to this day. Other centers have presented in great detail their protocol to minimize complications; 20, 33, 35 we agree with many of these, and offer our key points in summary below.
Like others, we use antistaphylococcal antibiotic ad ministration within 1 hour of skin incision. 20, 33 We choose to clip all hair on the patient's head followed by chlorhex idine skin prep; shaving with a razor is avoided, as is tem porary externalization of the leads. 9 Meticulous draping of the frame and of the scalp must be performed, with no openings to the patient.
Some authors have conjectured 33 and proven 9 that straight incisions resulted in worse infection risk than curvilinear ones. In bilateral implantations, we routinely use a slightly curved bifrontal incision slightly anterior to the coronal suture and bur holes. Likewise, the parietal incision is curvilinear but perpendicular to the axis of lead passage; grooves are made in the skull to recess the lead-extension connection and thus decrease the profile here as well.
The use of copious amounts of diluted povidoneio dine irrigation (1% concentration) for both Stage 1 and Stage 2 procedures prior to closure must also be under scored. Povidoneiodine has bactericidal activity against a wide spectrum of pathogens, including MRSA, and is maximally effective against MRSA in a dilution of 1:25 to 1:200 (0.5-4% betadine). 1, 7, 11 This has been shown to be superior to saline irrigation alone.
7,8 Haines 14 conclud edthatbacitracinirrigationinneurosurgeryisbeneficial for surgical wounds with high infection risk (> 15%), but additionally that there is no scientific evidence to sup port the use of prophylactic topical antibiotics for wounds with a risk of infection less than 5%. Indeed, our use of povidoneiodine has possibly contributed to minimiz ing our patient infections, possibly due to its bactericidal activity. Other groups that performed DBS surgery have experienced success in reducing their own patient infec tion rates using other antibacterial applications prior to wound closure; 25 the need for a more systematic review of intraoperative agents is apparent.
The routine postoperative administration of oral staphylococcalprophylaxisviacephalexin(orciprofloxa cin/clindamycin in penicillin allergy) for 7 days following each procedure also could potentially contribute to this low infection rate, but this cannot be adequately proven nor supported. There is only anecdotal evidence to sup port the extended use of perioperative antibiotics after implantation of devices into the CNS. The use of systemic antibiotic prophylaxis for more than 24 hours after ven triculoperitoneal shunting is uncertain, as concluded by a recent metaanalysis. 29 What has been demonstrated, aside from evidence suggesting decreased postoperative infection with anti bioticimpregnated devices (such as catheters in shunt ing 32 ) and frequent glove changing, 30 is that reducing op erative time is directly associated with reduced infection risk during implantation procedures. 2, 19, 36 The procedural time from incision to closure is routinely under 2 hours for a Stage 1 bilateral lead placement; Stage 2 procedure time is 30 minutes on average. It is important to minimize handling of the implant, reduce operating room traffic, give attention to meticulous surgical tissue manipulation, and work with an experienced team. 28 As with ventriculoperitoneal shunting procedures, there is likely to be a wide variability in infection rates following implantation of DBS hardware; this rate varies by surgeon performing the implantation, hospital, patient, and likely additional unknown factors, as contended by a recent retrospective cohort study. 34 The more systematic and regimented a procedure that can be performed, the easierextraneousfactorscanbeidentifiedandremoved to decrease complications.
Conclusions
In a large series of new DBS hardware implantations, the incidence of postoperative wound dehiscence and/or infections requiring further surgery was 1.24%. Standard for all implantations was a short procedural time, copious povidoneiodine irrigation, and postoperative antibiotic administration. Wound washout and/or partial hardware removal should be initially attempted for infection, de pending on the individual case; debridement alone is suc cessful in dehiscence without infection.
